Co-Diagnostics, Inc. - 10-Q Filing

Co-Diagnostics, Inc. reports Q3 fiscal 2026 results including new equity distribution agreements and private placement with Maxim Group LLC.

SEC EDGAR ·

Tickers: $CODX

Read the full article at SEC EDGAR

More Regulatory news